Trial Profile
An Open Label Study to Assess the Safety, Tolerability and Efficacy of Frovatriptan in the Prevention of Menstrually Associated Migraine (MAM) Headaches.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 Dec 2009
Price :
$35
*
At a glance
- Drugs Frovatriptan (Primary)
- Indications Menstrual migraine
- Focus Adverse reactions
- Sponsors Endo Pharmaceuticals
- 25 Dec 2009 New trial record